Levels of the Candida metabolite D-arabinitol in sera of steroid-treated and untreated patients with sarcoidosis

B. Wong, R. P. Baughman, K. L. Brauer

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

We measured the Candida metabolite D-arabinitol and its enantiomer L-arabinitol in 42 serum samples from 33 patients with sarcoidosis and compared the results with those from 27 healthy adults and 4 patients with candidiasis. The D- and L-arabinitol concentrations and the D- and L-arabinitol/creatinine ratios did not differ significantly in the sarcoidosis patients and the controls; the D-arabinitol concentrations and the D-arabinitol/creatinine ratios were much higher in the paitnets with candidiasis. Among the patients with sarcoidosis, the D- and L-arabinitol levels in the steroid recepients did not differ significantly from those in patients not receiving steroids. Higher D-arabinitol/creatinine ratios were associated with roentgenographic evidence of pulmonary fibrosis and low forced vital capacities, but not with disease activity as determined by the proportion of lymphocytes to total nucleated cells in bronchoalveolar lavage fluid or the CD4/CD8 ratio in bronchoalveolar lymphocytes. We conclude that neither sarcoidosis nor corticosteroid treatment is associated with high levels of D-arabinitol in serum.

Original languageEnglish (US)
Pages (from-to)1859-1862
Number of pages4
JournalJournal of Clinical Microbiology
Volume27
Issue number8
DOIs
StatePublished - 1989

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Levels of the Candida metabolite D-arabinitol in sera of steroid-treated and untreated patients with sarcoidosis'. Together they form a unique fingerprint.

  • Cite this